Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.107 | uM | 14715.203 | 0.0241 | -0.6846 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.00427 | uM | 14715.203 | 0.9474 | 0.9472 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.000853 | uM | 14715.203 | 0.8818 | 0.8791 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.000853 | uM | 14715.203 | 0.8818 | 0.8791 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.00427 | uM | 14715.203 | 0.9474 | 0.9472 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.107 | uM | 14715.203 | 0.0241 | -0.6846 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.533 | uM | 14715.203 | 0.0132 | -0.7658 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 2.67 | uM | 14715.203 | 0.0100 | -0.7958 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.533 | uM | 14715.203 | 0.0132 | -0.7658 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 2.67 | uM | 14715.203 | 0.0100 | -0.7958 | 2.0168 | |
| 21PT | HER2amp | - | Bortezomib | Proteasome | Proteasome | 0.000171 | uM | 14715.203 | 0.9530 | 0.9528 | 2.0168 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.4 | uM | 9120.021 | 1.0008 | 1.0025 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 2 | uM | 9120.021 | 0.9953 | 0.9854 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.00064 | uM | 9120.021 | 1.0512 | 1.1599 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.0032 | uM | 9120.021 | 0.9659 | 0.8959 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 250 | uM | 9118.017 | 0.2061 | -0.5620 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.016 | uM | 9120.021 | 1.0386 | 1.1202 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.08 | uM | 9120.021 | 1.0014 | 1.0044 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 10 | uM | 9120.021 | 1.0225 | 1.0698 | 0.6486 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 50 | uM | 9118.017 | 0.2654 | -0.4413 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.016 | uM | 9118.017 | 1.0299 | 1.0574 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.08 | uM | 9118.017 | 1.0049 | 1.0095 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 0.4 | uM | 9118.017 | 1.0219 | 1.0421 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 2 | uM | 9118.017 | 0.9793 | 0.9601 | 1.0401 | |
| 600MPE | HR+ | Luminal | Cisplatin | DNA cross-linker | DNA cross-linker | 10 | uM | 9118.017 | 0.8611 | 0.7322 | 1.0401 |